Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Leukemia, B-Cell × Observation × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1

Conditions

Breast Neoplasms 19 Prostatic Neoplasms 18 Carcinoma, Non-Small-Cell Lung 16 Neoplasms 15 Endometrial Neoplasms 13 Colorectal Neoplasms 12 Stomach Neoplasms 11 Lung Neoplasms 11 Pancreatic Neoplasms 9 Carcinoma, Hepatocellular 7 Oropharyngeal Neoplasms 6 Multiple Myeloma 6 Lymphoma, Large B-Cell, Diffuse 6 Leukemia, Myeloid, Acute 6 Esophageal Neoplasms 6 Colonic Neoplasms 6 Sarcoma 5 Neoplasm Metastasis 5 Mouth Neoplasms 5 Melanoma 5 Uterine Cervical Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Recurrence 4 Head and Neck Neoplasms 4 Colorectal Neoplasms, Hereditary Nonpolyposis 4 Brain Neoplasms 4 Anus Neoplasms 4 Urinary Bladder Neoplasms 3 Rectal Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3

Interventions

Cyclophosphamide 16 ofatumumab 12 ibrutinib 10 fludarabine 10 Rituximab 9 fludarabine phosphate 8 acalabrutinib 6 venetoclax 5 obinutuzumab 5 Lenalidomide 5 Bendamustine Hydrochloride 5 Vincristine 4 Melphalan 4 Whole-Body Irradiation 3 Mycophenolic Acid 3 Mesna 3 Immunotherapy, Adoptive 3 Chlorambucil 3 Alemtuzumab 3 spebrutinib 2 pirtobrutinib 2 navitoclax 2 idelalisib 2 Tacrolimus 2 Tablets 2 Stem Cell Transplantation 2 Peripheral Blood Stem Cell Transplantation 2 Patient Reported Outcome Measures 2 KW-2478 2 Doxorubicin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01039376 2019-07-30

PROLONG

Novartis

Phase 3 Terminated

480 enrolled 30 charts

LymphoidOther hematologic neoplasm

Leukemia, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡